EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models

Maria Lambouras, Charlotte Roelofs, Melrine Pereira, Emily Gruber iD, Jessica L Vieusseux, Patrick Lanteri, Cameron N Johnstone iD, Fenella Muntz, Sandra O'Toole, Lisa M Ooms iD, Christina A Mitchell, Robin L Anderson iD und 1 weitere

International Journal of Molecular Sciences · 16.03.2023 · 24 (6) · 5666

DOI: 10.3390/ijms24065666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.03.2023. Verfasst von Maria Lambouras und 12 weiteren Autor:innen. Beteiligte Einrichtung: Breast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Tamoxifen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Cancer Agency, VCA mid-career fellowship, Peter Mac Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estrogen receptor-positive breast cancers (ER+ BCas) are the most common form of BCa and are increasing in incidence, largely due to changes in reproductive practices in recent decades. Tamoxifen is prescribed as a component of standard-of-care endocrine therapy for the treatment and prevention of ER+ BCa. However, it is poorly tolerated, leading to low uptake of the drug in the preventative setting. Alternative therapies and preventatives for ER+ BCa are needed but development is hampered due to a paucity of syngeneic ER+ preclinical mouse models that allow pre-clinical experimentation in immunocompetent mice. Two ER-positive models, J110 and SSM3, have been reported in addition to other tumour models occasionally shown to express ER (for example 4T1.2, 67NR, EO771, D2.0R and D2A1). Here, we have assessed ER expression and protein levels in seven mouse mammary tumour cell lines and their corresponding tumours, in addition to their cellular composition, tamoxifen sensitivity and molecular phenotype. By immunohistochemical assessment, SSM3 and, to a lesser extent, 67NR cells are ER+. Using flow cytometry and transcript expression we show that SSM3 cells are luminal in nature, whilst D2.0R and J110 cells are stromal/basal. The remainder are also stromal/basal in nature; displaying a stromal or basal Epcam/CD49f FACS phenotype and stromal and basal gene expression signatures are overrepresented in their transcript profile. Consistent with a luminal identity for SSM3 cells, they also show sensitivity to tamoxifen in vitro and in vivo. In conclusion, the data indicate that the SSM3 syngeneic cell line is the only definitively ER+ mouse mammary tumour cell line widely available for pre-clinical research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, EstrogenTamoxifenHumansCell Line, TumorAnimalsMiceDisease Models, AnimalPhenotypeImmunohistochemistryFlow CytometryTranscriptomeMice, 129 StrainRNA-SeqEpithelial CellsMammary Glands, AnimalMammary Neoplasms, Experimental

Stichwörter der Autor:innen

breast cancer cell lineestrogen receptor-positivemouse modelssyngeneic

Substanzen

Receptors, EstrogenTamoxifen

Autor:innen und Institutionen

  • Breast Cancer Risk and Prevention Laboratory, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
  • Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC 3800, Australia.
  • Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia.
  • The Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
  • Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia.
  • School of Cancer Medicine, La Trobe University, Heidelberg, VIC 3084, Australia.

ORCID-Profile: Emily Gruber, Cameron N Johnstone, Lisa M Ooms, Robin L Anderson

Förderung

  • Victorian Cancer Agency
  • VCA mid-career fellowship
  • Peter Mac Foundation
  • Australian Government Research Training Program (RTP) Scholarship
  • La Trobe University
  • Tour de Cure
  • State Trustees
  • NHMRC

Zitieren

APA

Lambouras, M., Roelofs, C., Pereira, M., Gruber, E., Vieusseux, J. L., Lanteri, P., Johnstone, C. N., Muntz, F., O'Toole, S., Ooms, L. M., Mitchell, C. A., Anderson, R. L., & Britt, K. L. (2023). Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models. International Journal of Molecular Sciences, 24(6), 5666. https://doi.org/10.3390/ijms24065666

Vancouver

Lambouras M, Roelofs C, Pereira M, Gruber E, Vieusseux JL, Lanteri P, et al. Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models. International Journal of Molecular Sciences. 2023;24(6):5666. doi:10.3390/ijms24065666

BibTeX
@article{Lambouras2023,
  author = {Lambouras, Maria and Roelofs, Charlotte and Pereira, Melrine and Gruber, Emily and Vieusseux, Jessica L and Lanteri, Patrick and Johnstone, Cameron N and Muntz, Fenella and O'Toole, Sandra and Ooms, Lisa M and Mitchell, Christina A and Anderson, Robin L and Britt, Kara L},
  title = {Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {5666},
  doi = {10.3390/ijms24065666}
}
Kostenlos starten →